Full-Time

Microservices and AWS Admin

Posted on 5/19/2025

Solventum

Solventum

5,001-10,000 employees

Healthcare solutions for improved patient outcomes

No salary listed

Mid, Senior

Bengaluru, Karnataka, India

In Person

Category
DevOps & Infrastructure
Cloud Engineering
Required Skills
Kubernetes
Python
Grafana
Git
Apache Kafka
Docker
CloudFormation
AWS
Prometheus
Jenkins
Splunk
Linux/Unix
Requirements
  • 3 to 5 years of expertise in AWS (EKS, ECS, MSK), Kubernetes, Kafka, Docker and CI/CD automation
  • Strong experience with AWS services: EKS, ECS, MSK, CodePipeline and CloudFormation (must-have)
  • Hands-on experience with Kafka and AWS MSK (must-have)
  • Good knowledge of Kubernetes (on-prem and AWS) and Docker (must-have)
  • Experience with CI/CD tools: Jenkins, GitHub/Bitbucket, AWS CodePipeline (must-have)
  • Scripting skills in YAML or JSON (must-have), Python and Shell (add-ons)
  • Familiarity with monitoring tools: Splunk (Prometheus, Grafana as add-ons)
  • Working knowledge of Linux OS, preferably RHEL
  • Strong troubleshooting, communication, and team collaboration skills
Responsibilities
  • Set up and manage production-ready infrastructure for EKS, ECS, MSK and AWS CodePipeline
  • Manage and operate Kafka and AWS MSK clusters with EKS/ECS
  • Maintain and support CI/CD pipelines using Jenkins and AWS tools
  • Build, deploy and troubleshoot Docker-based applications on Kubernetes and ECS
  • Use CloudFormation for infrastructure automation
  • Automate tasks using JSON, YAML, Shell scripts and Python
  • Integrate tools like Splunk and SonarQube for monitoring and quality checks
Desired Qualifications
  • AWS Certified Solution Architect
  • Certified Kubernetes Administrator (CKA)

Solventum focuses on enhancing healthcare by providing solutions that aim to improve the quality and safety of medical services. Their products are designed to streamline healthcare processes, making them more efficient and user-friendly for both providers and patients. Unlike many competitors, Solventum emphasizes a continuous problem-solving approach, ensuring that they adapt and respond to the evolving needs of the healthcare industry. The main goal of Solventum is to create a healthcare environment that is not only effective but also prioritizes the well-being of individuals.

Company Size

5,001-10,000

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven predictive maintenance can enhance Solventum's product reliability and efficiency.
  • Blockchain integration can improve transparency and compliance in sterilization processes.
  • Growing demand for eco-friendly sterilization methods benefits Solventum's VH2O2 solutions.

What critics are saying

  • Increased competition may reduce Solventum's market share in sterilization products.
  • Supply chain disruptions could delay production of VH2O2 Clear Challenge Pack.
  • Regulatory changes may delay Solventum's new product approvals.

What makes Solventum unique

  • Solventum's Attest™ VH2O2 Pack is the first FDA-cleared preassembled test pack.
  • Partnership with SprintRay focuses on same-day dental restorations using 3D printing.
  • Solventum's eBowie-Dick System automates sterilization testing, eliminating manual result interpretation.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance

Company News

PR Newswire
Jun 9th, 2025
Solventum Launches Preassembled, See-Through Vh2O2 Test Pack For Low-Temp Medical Instrument Sterilization

The Attest™ Super Rapid VH2O2 Clear Challenge Pack integrates biological and chemical performance indicators in a ready-to-use design to support every load monitoring1U.S. hospital infections affect 1 in 31 patients;2 new all-in-one solution is aimed at making expert-recommended safety practices in steam sterilization3 feasible for VH2O2 low-temperature methodTest pack is U.S. FDA-cleared for routine monitoring across multiple sterilizer brands, models and cycle types, and is designed to streamline workflow and simplify inventory management for sterile processing teamsST PAUL, Minn., June 9, 2025 /PRNewswire/ -- Solventum, a global MedTech leader at the forefront of infection prevention innovation, today announced the launch of its Attest™ Super Rapid Vaporized Hydrogen Peroxide (VH2O2) Clear Challenge Pack. The ready-to-use test integrates two previously FDA-cleared indicators – a biological indicator (BI) for confirming microbial neutralization and a chemical indicator (CI) for verifying proper sterilizer function – into a single-use test pack with a transparent container.Attest™ Super Rapid VH2O2 Clear Challenge PackMedical instrument sterility is a critical component in the fight against hospital-associated infections, which impact one in every 31 hospital patients in the U.S.4 The practice of every load monitoring – using dual indicators (both BIs and CIs) to verify the efficacy of every sterilization cycle for each batch of instruments – is recommended by industry guidelines and expert consensus to help minimize patient safety risks.This unique combination makes the Attest™ Super Rapid VH2O2 Clear Challenge Pack the first and only preassembled VH2O2 test pack that is U.S. FDA-cleared for routine monitoring across multiple sterilizer brands, models and cycle types*, offering:Convenience: preassembled, ready-to-use pack eliminates the step of assembling testing pouches with separate indicators, saving time and mitigating the risk of errors inherent to manual preparation, like incorrect indicator placement or omission of an indicator.preassembled, ready-to-use pack eliminates the step of assembling testing pouches with separate indicators, saving time and mitigating the risk of errors inherent to manual preparation, like incorrect indicator placement or omission of an indicator. Accuracy: engineered to more accurately simulate the environment within a wrapped set of surgical instruments during a VH2O2 cycle

PR Newswire
Apr 17th, 2025
Solventum To Report First Quarter Fiscal 2025 Earnings On May 8, 2025

ST. PAUL, Minn., April 17, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its first quarter fiscal 2025 financial results on Thursday, May 8, 2025, after the U.S. financial markets close. After the release, Solventum management will host a webcast to discuss the results and its business. Other forward-looking and material information may also be discussed during the webcast

PR Newswire
Mar 25th, 2025
Solventum Partners With Sprintray To Disrupt The Digital Dentistry Market With High-Quality, Permanent Same-Day Restorations

In this first-of-its-kind partnership for its Dental Solutions business, Solventum, formerly 3M Health Care, is striving to focus on longevity and durability of permanent same-day restorative dental offerings, reaffirming its commitment to solving industry's toughest problemsPartnership aims to integrate innovative new material science and disruptive technology like chairside 3D printing to optimize workflows, enhance procedural efficiency and benefit both patients and practitioners ST. PAUL, Minn., March 25, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV), the leader in dental composites and restorative dentistry, today announced a strategic partnership with SprintRay, a leading provider of chairside 3D dental printing, to meet the needs of dentists with in-office chairside 3D printed crowns, inlays, onlays and more. This research and development (RD) and commercialization agreement is focused on developing and bringing to market high-quality, durable and permanent same-day restorations – with the quality patients and dentists expect from the current multi-visit laboratory fabricated procedures

PR Newswire
Mar 12th, 2025
Solventum Launches Attest™ Ebowie-Dick Test System Revolutionizing Sterilization Assurance

ST. PAUL, Minn., March 12, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV), formerly 3M Health Care, today announced the launch of the Attest™ eBowie-Dick Test System (eBowie-Dick System), an electronic test card and auto-reader for sterilization testing that eliminates the need for visual interpretation of results and manual documentation

INACTIVE